Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA
From The IMID Forum by The Immune-Mediated Inflammatory Disease Forum
February 27, 2026 · 9 min
About this episode
Professor Iain McInnes reviews recent research on the effectiveness of JAK inhibitors in treating pain in RA and PsA patients.
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Taylor et al. where authors report the effects of UPA and ADA on pain in patients with active RA or PsA stratified by inflammatory status, and a paper by Sonomoto et al. which shows the effectiveness of TOF, BAR, UPA and FIL in patients with RA.
People in this episode
Host: Professor Iain McInnes
Topics covered
- Rheumatoid Arthritis
- Psoriatic Arthritis
- JAK inhibitors
- Pain outcomes
- Drug effectiveness
Keywords
- Rheumatoid Arthritis
- Psoriatic Arthritis
- JAK inhibitors
- pain outcomes
- drug effectiveness
Mentioned in this episode
Organizations: Taylor et al., Sonomoto et al.
Products: UPA, ADA, TOF, BAR, FIL
Places: RA, PsA
More episodes of The IMID Forum
- EULAR 2026 Review Podcast · June 12, 2026 · 40 min
- EULAR 2026 Day 4 Highlights Podcast · June 6, 2026 · 5 min
- EULAR 2026 Day 3 Highlights Podcast · June 5, 2026 · 3 min
- EULAR 2026 Day 2 Highlights Podcast · June 4, 2026 · 6 min
- EULAR 2025 Day 1 Highlights Podcast · June 3, 2026 · 6 min
- Discussing RA: Comparative outcomes with upadacitinib in RA · May 28, 2026 · 9 min
Explore listener stats, chart rankings, contacts and more on the The IMID Forum podcast page.